NCT06483724

Brief Summary

The study will compare a modified surgical approach for preserving fertility and minimizing hemorrhage in morbidly adherent placenta during cesarean section with a cervical tourniquet against uterine artery ligation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 25, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 3, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

July 5, 2024

Status Verified

July 1, 2024

Enrollment Period

9 months

First QC Date

June 25, 2024

Last Update Submit

July 2, 2024

Conditions

Outcome Measures

Primary Outcomes (17)

  • operation time

    recording total time of the surgery

    intraoperative

  • repair time

    recording length of defect repair from placental separation until uterine wall closure

    intraoperative

  • Estimated blood loss

    recording amount of blood loss

    intraoperative

  • packed red blood cells transfusion

    recording amount of red blood cell transfused

    intraoperative until 24 hours after surgery

  • fresh frozen plasma (FFP) transfusion

    recording amount of FFP transfusion

    intraoperative until 24 hours postoperative

  • Number of Participants who had Bladder injuries

    Number of Participants who had Bladder injuries

    intraoperative until 2 weeks post operative

  • Number of Participants who had ureteral injuries

    Number of Participants who had ureteral injuries

    intraoperative until 2 weeks post operative

  • Number of Participants who had bowel injury

    Number of Participants who had bowel injury

    intraoperative until 2 weeks post operative

  • surgical site infection

    record the presence of wound infection

    24 hours until 1 month after surgery

  • urine output

    recording amount of urine output

    intraoperative

  • internal iliac artery ligation

    recording if the internal iliac artery ligated whether it was unilateral or bilateral

    intraoperative

  • pre-operative hemoglobin

    recording amount of hemoglobin

    preoperative

  • post-operative hemoglobin

    recording amount of hemoglobin

    postoperative within 6 hours from surgery

  • hospital stay

    recording duration of hospital stay after surgery

    postoperative until 10 days after surgery

  • ICU admission

    recording the number of patients admitted to the ICU

    immediate postoperative until 5 days after surgery

  • HDU high dependency unit admission

    recording the number of patients admitted to high dependency unit

    postoperative until 10 days after surgery

  • surgical diagnosis

    strategy to preserving the uterus when managing placenta accreta versus hysterectomy

    intraoperative

Study Arms (2)

Group 1 (n = 41) cervical tourniquet

EXPERIMENTAL

in group 1 the investigators using a sterile Foley catheter (Ch 16/18 French) down to the lowest point and secures it "en bloc" around the cervix at the level of the uterosacral ligaments, approximately 3-4 cm below the incision. Then, tighten and fix .

Procedure: cervical tourniquet

Group 2 (n=41) uterine artery ligation

EXPERIMENTAL

in group 2the investigators ligated the uterine vessels in a continuous manner at the level of the utero-vesical fold on each side.

Procedure: uterine artery ligation

Interventions

After opening the abdominal wall, To reduce bleeding during PAS, make the uterine incision above the placenta's intrauterine borders . 2-investigators extract the uterus from the abdomen 3-An assistant slides a sterile Foley catheter (Ch 16/18 French) down to the lowest point and secures it "en bloc" around the cervix 4-The bladder peritoneum is isolated from the uterus 5-To remove myometrial tissue, leave a margin of at least 2 cm superior to the cervical internal ostium using electrocautery or scissors .

Group 1 (n = 41) cervical tourniquet

After opening the abdominal wall, To reduce bleeding during PAS, make the uterine incision above the placenta's intrauterine borders . 2-investigators extract the uterus from the abdomen 3-The bladder peritoneum is isolated from the uterus 4-The uterine vessels were ligated in continuity at the level of the utero-vesical fold on each side 5-To remove myometrial tissue, leave a margin of at least 2 cm superior to the cervical internal ostium using electrocautery or scissors .

Group 2 (n=41) uterine artery ligation

Eligibility Criteria

Age18 Years - 38 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed sonographically to have placenta accreta spectrum .
  • Pregnancy is singleton and fetus is alive.
  • Elective caesarean section done from 36 gestational weeks

You may not qualify if:

  • Patients requesting hysterectomy
  • Coexisting uterine pathology such as fibroids or gynaecological malignancies
  • Patients with bleeding diathesis.
  • Morbid obesity of BMI \>40.
  • Patients having labour pains or vaginal bleeding before scheduled intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Placenta Accreta

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

June 25, 2024

First Posted

July 3, 2024

Study Start

July 1, 2024

Primary Completion

April 1, 2025

Study Completion

May 1, 2025

Last Updated

July 5, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share